Announced
Completed
Financials
Tags
deep learning
Friendly
Acquisition
Private Equity
Software
Cross Border
Single Bidder
Minority
artificial intelligence
Completed
Venture Capital
France
Private
Synopsis
M Ventures, a strategic corporate venture capital fund, and Debiopharm, an independent biopharmaceutical company, led a €15m Series A funding in Iktos, a deep learning technology platform, with participation from Omnes Capital, a private equity firm. “The technologies we have developed have been enabling multiple partners in realizing this promise. We welcome our new, experienced, investor syndicate and fresh financing that will allow us to execute our plan of being the preferred partner for the industry to address their drug development needs,” Yann Gaston-Mathé, Iktos President and Co-Founder.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.